REG - JPMorgan Sec.Plc Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI)- Takeda Pharma CoLtd AMENDMNT

Takeda Pharmaceutical CoAnnouncement

13/11/2018 14:30

RNS Number : 2286H
JPMorgan Securities Plc
13 November 2018
 


AMENDMENT
INCREASED EQUITY PURCHASES BY 5,300 TO 27,600
ADDED EQUITY SWAP PURCHASES OF 428,000
ADDED EQUITY SWAP SALES OF 214,000
FORM 8.5 (EPT/RI)
 
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


J.P. Morgan Securities Plc




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Joint Financial Adviser to Takeda Pharmaceutical Company Limited




(d) Date dealing undertaken:


06 November 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
     If it is a cash offer or possible cash offer, state "N/A"


Yes, Shire plc
 



 
2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


Purchases/ sales
 


Total number of securities


Highest price per unit paid/received
(JPY)


Lowest price per unit paid/received
(JPY)




Common Stock


Purchases
 
Sales


27,600
 
45,045


4645.4375
 
4645.4375


4616.0000
 
4603.8958



 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit
 
 
 




Common Stock


Equity Swaps


Long
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short


428,000
214,000
100
19,800
200
200
4,900
200
200
100
100
400
2,700
200
23,600
 
214,000
100
63,000
95,500
600
55,500
100
100
400
48,300
400
2,700


40.7571 USD
40.8113 USD
4,612.0000 JPY
4,613.4697 JPY
4,621.9222 JPY
4,627.6066 JPY
4,627.6123 JPY
4,628.0000 JPY
4,629.5833 JPY
4,633.0000 JPY
4,636.7450 JPY
4,641.5000 JPY
4,650.3704 JPY
4,652.0000 JPY
4,663.4746 JPY
 
40.8113 USD
4,617.0000 JPY
4,617.0238 JPY
4,624.9330 JPY
4,628.0000 JPY
4,629.3892 JPY
4,632.0000 JPY
4,637.0000 JPY
4,637.6674 JPY
4,639.5926 JPY
4,641.7553 JPY
4,650.7192 JPY



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit
 


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit
 





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit
 




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)








 
 











 
3.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




None
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




None
 



 
 



Date of disclosure:


13 November 2018




Contact name:


Alwyn Basch




Telephone number:


020 7742 7407



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFFMFLDFASEEF